cryptotanshinone has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, H; Kageyama, S; Kawauchi, A; Kim, CJ; Minami, K; Shirasawa, S; Tambe, Y; Tanaka, H; Terado, T; Tsunoda, T; Ushio, A | 1 |
| Inoue, H; Kageyama, S; Kawauchi, A; Kim, CJ; Mukaisho, KI; Tambe, Y; Terado, T | 1 |
| Chen, Z; Cheng, R; Ge, Y; Yang, B | 1 |
3 other study(ies) available for cryptotanshinone and Pancreatic Neoplasms
| Article | Year |
|---|---|
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells.
Topics: Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Glutamine; Humans; Lipids; Lipogenesis; Pancreatic Neoplasms; Phenanthrenes; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species; Signal Transduction | 2022 |
Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
Topics: Animals; Antigens, CD; Antineoplastic Agents; beta Catenin; Cadherins; Cell Line, Tumor; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phenanthrenes; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Spheroids, Cellular; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Cryptotanshinone suppresses the proliferation and induces the apoptosis of pancreatic cancer cells via the STAT3 signaling pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Pancreas; Pancreatic Neoplasms; Phenanthrenes; Salvia miltiorrhiza; Signal Transduction; STAT3 Transcription Factor | 2015 |